TABLE 1.
Demographic and clinical characteristics of evaluable subjects
| Category | No. of patients (%) |
|---|---|
| Age (yr)a | |
| 14–17 | 5 (0.3) |
| 18–29 | 554 (36.9) |
| 30–39 | 485 (32.3) |
| 40–49 | 247 (16.5) |
| ≥50 | 210 (14.0) |
| Race/ethnicity | |
| Asian | 74 (4.9) |
| Black/African American | 753 (50.2) |
| White (Hispanic/Latino) | 269 (17.9) |
| White (not Hispanic/Latino) | 341 (22.7) |
| Otherb | 64 (4.3) |
| Geographic region | |
| Mid-Atlantic | 244 (16.3) |
| Northeast | 220 (14.7) |
| Northwest | 49 (3.3) |
| Southeast | 571 (38.0) |
| Southwest | 417 (27.8) |
| Site type | |
| Clinical research center | 659 (43.9) |
| Family planning clinic | 282 (18.8) |
| Hospital system high-risk STI clinic | 18 (1.2) |
| Obstetrics and gynecology clinic | 467 (31.1) |
| Public health clinic | 75 (5.0) |
| Subject-reported symptomsc | |
| Abnormal vaginal discharge | 1,230 (81.9) |
| Vaginal odor | 853 (56.8) |
| Genital itching/irritation/burning/soreness | 933 (62.2) |
| Pain during sex and/or urination | 371 (24.7) |
| Edema | 127 (8.5) |
| Erythema | 138 (9.2) |
| Other | 30 (2.0) |
| Pregnant | |
| Yes | 21 (1.4) |
| No | 1,474 (98.2) |
| Unspecified | 6 (0.4) |
| Menstrual status | |
| With menses | 120 (8.0) |
| Without menses | 1,224 (81.5) |
| Postmenopausal | 157 (10.5) |
| Diagnosed with HIV | |
| Yes | 14 (0.9) |
| No | 1,467 (97.7) |
| Unspecified | 20 (1.3) |
| History of recurrent symptoms within 12 mo | |
| No | 623 (41.5) |
| Yes | 874 (58.2) |
| 1 or 2 occurrences | 396 (45.9) |
| 3 or 4 occurrences | 242 (28.1) |
| >4 occurrences | 224 (26.0) |
| Unknown | 4 (0.3) |
| Use of feminine products within 4 wk | |
| Yes | 305 (20.3) |
a
The median age was 33.0 years (minimum, 14 years; maximum, 79 years). The mean age was 35.3 years ± 11.74 years (standard deviation).
b
Includes patient-reported other, mixed, and unknown races.
c
May report multiple responses.